Avanos Medical, Inc.
AVNS
$24.96
$0.000.00%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.72% | 1.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.72% | 1.74% | |||
| Cost of Revenue | -7.27% | 3.38% | |||
| Gross Profit | 9.53% | 0.00% | |||
| SG&A Expenses | -14.09% | 15.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 271.43% | -160.87% | |||
| Total Operating Expenses | -2.76% | 0.00% | |||
| Operating Income | 172.22% | 620.00% | |||
| Income Before Tax | 533.33% | 200.00% | |||
| Income Tax Expenses | 0.00% | 1,150.00% | |||
| Earnings from Continuing Operations | 492.31% | 7.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 492.31% | 7.14% | |||
| EBIT | 172.22% | 620.00% | |||
| EBITDA | 48.15% | 36.36% | |||
| EPS Basic | 491.79% | 7.28% | |||
| Normalized Basic EPS | 268.39% | 387.04% | |||
| EPS Diluted | 491.79% | 7.28% | |||
| Normalized Diluted EPS | 260.65% | 387.04% | |||
| Average Basic Shares Outstanding | 0.22% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.37% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||